Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Maltodextrin for Cardiac Function in CABG Patients with Reduced LVEF
NCT05188222Phase 4Not yet recruiting
- Sponsor
- Jewish General Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by Jewish General Hospital. Primary endpoint: Intraoperative three-dimensional left ventricular ejection fraction. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05188222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05188222.